Learn more

MEDIZINISCHE UNIVERSITÄT WIEN

Overview
  • Total Patents
    55
  • GoodIP Patent Rank
    35,970
  • Filing trend
    ⇩ 100.0%
About

MEDIZINISCHE UNIVERSITÄT WIEN has a total of 55 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are UCL BIOMEDICA PLC, BRITISH COLUMBIA CANCER AGENCY BRANCH and UNIV VIRGINIA.

Patent filings per year

Chart showing MEDIZINISCHE UNIVERSITÄT WIENs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Marculescu Rodrig 8
#2 Haschemi Arvand 8
#3 Wagner Oswald 8
#4 Nagy Csörsz 8
#5 Mastalir Matthias 6
#6 Chiba Peter 6
#7 Gstach Hubert 6
#8 Valenta Rudolf 4
#9 Madritsch Christoph 4
#10 Flicker Sabine 4

Latest patents

Publication Filing date Title
WO2020169577A1 New recombinant diamine oxidase and its use for the treatment of diseases characterized by excess histamine
EP3711674A1 Method for acquiring image data of a body part
EP3282019A1 Genotyping and treatment of cancer, in particular chronic lymphocytic leukemia
WO2017025535A1 Method for isolating antibodies reactive to cryptotopes of a pathogen
EP3282272A1 Phase offset determination in magnetic resonance imaging
WO2015185656A1 Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
WO2015185658A2 Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
WO2015185653A2 Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
EP3065086A1 Computerized device and method for processing image data
EP3056512A1 Antibody construct
WO2015089541A1 Aortic catheter
WO2015052570A1 Implant and method for improving coaptation of an atrioventricular valve
WO2015025054A1 Dye-specific antibodies for prestained molecular weight markers and methods producing the same
US2016030176A1 Implant and method for improving coaptation of an atrioventricular valve
EP2947460A1 Personalized therapy of inflammation-associated cancer using methods of assessing the susceptibility of a subject to the treatment with EGFR inhibitors/antagonists
AT515856A1 Surgical bone drilling apparatus, contra-angle for such a surgical bone drilling apparatus and method of cooling such a surgical bone drilling apparatus
EP2924045A1 New agents for the treatment of cancer
EP2921857A1 Soluble axl receptor tyrosine kinase in the diagnosis of cancer
MX2014014713A Amidophenoxypropanolamines.
EP2781219A1 Use of sedoheptulose for prevention or treatment of inflammation